Parikh R, Kurosky SK, Udall M, Chang J, Cappelleri JC, Doherty JP, Kaye JA. Treatment patterns and health outcomes in platinum-refractory or platinum-resistant ovarian cancer: a retrospective medical record review. Int J Gynecol Cancer. 2018 May;20(4):738-48. doi: 10.1097/IGC.0000000000001222
Saigi N, Espelt A, Folch C, Sarasa-Renedo A, Castellano Y, Majo X, Merono M, Brugal MT, Casabona J, REDAN Group. Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). Adicciones. 2014;26(1):69-76. doi: 10.20882/adicciones.136
Panish J, Karve S, Candrilli SD, Dirani R. Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US Medicaid-enrolled patients with schizophrenia. J Pharm Health Serv Res. 2013 Mar 1;4(1):29-39.
Goyal RK, Donga P, Sansgiry SS. Wait and watch approach in managing acute otitis media: current awareness, attitude and their relationship with the behavior among primary care physicians. J Pharm Health Serv Res. 2011;2:121-5.
Alverez SA, Bae-Jump V, Havrilesky LJ, Calingaert B, Clarke-Pearson ADL, Soper JT, Gehrig PA. Attitudes regarding the use of hematopoietic colony-stimulating factor utilization and maintenance of relative dose intensity among gynecologic oncologists. Int J Gynecol Cancer. 2009 Apr;19(3):447-54.
Lancaster JM, Sayer RA, Blanchette C, Calingaert B, Konidari I, Gray J, Schildkraut J, Schomberg DW, Marks JR, Berchuck A. High expression of insulin-like growth factor binding protein–2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer. 2006 Jul 1;16(4):1529-35.
Clarkson T, Anthony MS, Hughes C. Estrogenic soybean isoflavones and chronic disease: risks and benefits. Trends Endocrinol Metab. 1995 Jan;6(1):11-6.